189 related articles for article (PubMed ID: 30429408)
21. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
22. Clinical and radiological outcomes after intracranial atherosclerotic stroke: a comprehensive approach comparing stroke subtypes.
Kim SJ; Ryoo S; Kim GM; Chung CS; Lee KH; Bang OY
Cerebrovasc Dis; 2011; 31(5):427-34. PubMed ID: 21346347
[TBL] [Abstract][Full Text] [Related]
23. A case control study between diabetic and non-diabetic subjects with ischemic stroke.
Pinto A; Tuttolomondo A; Di Raimondo D; Di Sciacca R; Fernandez P; Di Gati M; Arnao V; Licata G
Int Angiol; 2007 Mar; 26(1):26-32. PubMed ID: 17353885
[TBL] [Abstract][Full Text] [Related]
24. Acute phase homocysteine related to severity and outcome of atherothrombotic stroke.
Wu XQ; Ding J; Ge AY; Liu FF; Wang X; Fan W
Eur J Intern Med; 2013 Jun; 24(4):362-7. PubMed ID: 23391475
[TBL] [Abstract][Full Text] [Related]
25. Pre-admission CHADS2, CHA2DS2-VASc, and R2CHADS2 Scores on Severity and Functional Outcome in Acute Ischemic Stroke with Atrial Fibrillation.
Tanaka K; Yamada T; Torii T; Furuta K; Matsumoto S; Yoshimura T; Takase K; Wakata Y; Nakashima N; Kira J; Murai H
J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1629-35. PubMed ID: 25906940
[TBL] [Abstract][Full Text] [Related]
26. Design and Rationale of the RELAXED (Recurrent Embolism Lessened by rivaroxaban, an Anti-Xa agent, of Early Dosing for acute ischemic stroke and transient ischemic attack with atrial fibrillation) Study.
Yasaka M; Minematsu K; Toyoda K; Yamagami H; Yoshimura S; Nagao T; Mori E; Hirano T; Hamasaki T; Yamaguchi T
J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1342-8. PubMed ID: 26987488
[TBL] [Abstract][Full Text] [Related]
27. Prevention strategies of cardioembolic ischemic stroke in Chagas' disease.
Sousa AS; Xavier SS; Freitas GR; Hasslocher-Moreno A
Arq Bras Cardiol; 2008 Nov; 91(5):306-10. PubMed ID: 19142374
[TBL] [Abstract][Full Text] [Related]
28. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke.
Patel SC; Levine SR; Tilley BC; Grotta JC; Lu M; Frankel M; Haley EC; Brott TG; Broderick JP; Horowitz S; Lyden PD; Lewandowski CA; Marler JR; Welch KM;
JAMA; 2001 Dec; 286(22):2830-8. PubMed ID: 11735758
[TBL] [Abstract][Full Text] [Related]
29. Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.
Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28780510
[TBL] [Abstract][Full Text] [Related]
30. The global burden of cerebral small vessel disease related to neurological deficit severity and clinical outcomes of acute ischemic stroke after IV rt-PA treatment.
Liu X; Li T; Diao S; Cai X; Kong Y; Zhang L; Wang Z; Li R; Zhou Y; Fang Q
Neurol Sci; 2019 Jun; 40(6):1157-1166. PubMed ID: 30830567
[TBL] [Abstract][Full Text] [Related]
31. Ischemic lacunar stroke in patients with and without potential mechanism other than small-artery disease.
Baumgartner RW; Sidler C; Mosso M; Georgiadis D
Stroke; 2003 Mar; 34(3):653-9. PubMed ID: 12624287
[TBL] [Abstract][Full Text] [Related]
32. Brain natriuretic peptide in acute ischemic stroke.
Maruyama K; Shiga T; Iijima M; Moriya S; Mizuno S; Toi S; Arai K; Ashihara K; Abe K; Uchiyama S
J Stroke Cerebrovasc Dis; 2014; 23(5):967-72. PubMed ID: 24119617
[TBL] [Abstract][Full Text] [Related]
33. Antecedent Aspirin Use Is Associated with Less Severe Symptoms on Admission for Ischemic Stroke.
Nelson S; Cloonan L; Kanakis AS; Fitzpatrick KM; Shideler KI; Perilla AS; Furie KL; Rost NS
J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2519-25. PubMed ID: 27444522
[TBL] [Abstract][Full Text] [Related]
34. Effect of previous statin therapy on severity and outcome in ischemic stroke patients: a population-based study.
Aboa-Eboulé C; Binquet C; Jacquin A; Hervieu M; Bonithon-Kopp C; Durier J; Giroud M; Béjot Y
J Neurol; 2013 Jan; 260(1):30-7. PubMed ID: 22729388
[TBL] [Abstract][Full Text] [Related]
35. The Interplay between Stroke Severity, Antiplatelet Use, and Aspirin Resistance in Ischemic Stroke.
Agayeva N; Topcuoglu MA; Arsava EM
J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):397-403. PubMed ID: 26576697
[TBL] [Abstract][Full Text] [Related]
36. Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator?
Hassan AE; Zacharatos H; Hassanzadeh B; El-Gengaihy A; AlKawi A; Shhadeh A; Kirmani JF
J Stroke Cerebrovasc Dis; 2010 Mar; 19(2):116-20. PubMed ID: 20189087
[TBL] [Abstract][Full Text] [Related]
37. A retrospective study on early carotid endarterectomy within 48 hours after transient ischemic attack and stroke in evolution.
Ferrero E; Ferri M; Viazzo A; Labate C; Berardi G; Pecchio A; Piazza S; Ripepi M; Nessi F
Ann Vasc Surg; 2014 Jan; 28(1):227-38. PubMed ID: 24011816
[TBL] [Abstract][Full Text] [Related]
38. Leukoaraiosis predicts poor 90-day outcome after acute large cerebral artery occlusion.
Henninger N; Lin E; Baker SP; Wakhloo AK; Takhtani D; Moonis M
Cerebrovasc Dis; 2012; 33(6):525-31. PubMed ID: 22538962
[TBL] [Abstract][Full Text] [Related]
39. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
Ong CT; Wong YS; Wu CS; Su YH
Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721
[TBL] [Abstract][Full Text] [Related]
40. Is asymptomatic hemorrhagic transformation really innocuous?
Park JH; Ko Y; Kim WJ; Jang MS; Yang MH; Han MK; Oh CW; Park SH; Lee J; Lee J; Bae HJ; Gorelick PB
Neurology; 2012 Feb; 78(6):421-6. PubMed ID: 22282643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
